Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Abnormal Ureteral Position With Adherant Ovary.

Woods SM, Dhari AS, Martin DC.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S223. doi: 10.1016/j.jmig.2015.08.788. Epub 2015 Oct 15. No abstract available.

PMID:
27679101
2.

High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?

Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G, Mariette C; FREGAT (French EsoGastric Tumor) working group - FRENCH (Fédération de Recherche en Chirurgie).

Ann Surg Oncol. 2015 Oct;22(11):3632-9. doi: 10.1245/s10434-015-4423-5. Epub 2015 Feb 13.

PMID:
25676845
3.

Perforated levonorgestrel-releasing intrauterine system resulting in small bowel obstruction: a case report.

Loveless A, Dhari A, Kilpatrick CC.

J Reprod Med. 2014 Nov-Dec;59(11-12):611-3.

PMID:
25552138
4.

Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.

Piessen G, Messager M, Lefevre JH, Goéré D, Mabrut JY, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C; FREGAT Working Group – FRENCH.

Eur J Surg Oncol. 2014 Dec;40(12):1746-55. doi: 10.1016/j.ejso.2014.04.019. Epub 2014 Jun 26.

PMID:
25012732
5.

The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.

Bekkar S, Gronnier C, Messager M, Robb WB, Piessen G, Mariette C; French Eso-Gastric Tumors Working Group-Fédération de Recherche en Chirurgie.

Ann Thorac Surg. 2014 Jan;97(1):303-10. doi: 10.1016/j.athoracsur.2013.09.010. Epub 2013 Nov 5.

PMID:
24200394
6.

Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma?

Gronnier C, Messager M, Robb WB, Thiebot T, Louis D, Luc G, Piessen G, Mariette C; FREGAT working group-FRENCH.

Surgery. 2013 Nov;154(5):1093-9. doi: 10.1016/j.surg.2013.05.020. Epub 2013 Sep 26. Review.

PMID:
24075273
7.

Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection.

Robb WB, Messager M, Goere D, Pichot-Delahaye V, Lefevre JH, Louis D, Guiramand J, Kraft K, Mariette C; FREGATWorking Group-FRENCH.

JAMA Surg. 2013 Jul;148(7):624-31. doi: 10.1001/jamasurg.2013.63.

PMID:
23552982
8.

Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.

Honoré C, Goéré D, Messager M, Souadka A, Dumont F, Piessen G, Elias D, Mariette C; FREGAT Working Group – FRENCH.

Eur J Surg Oncol. 2013 Mar;39(3):235-41. doi: 10.1016/j.ejso.2012.12.013. Epub 2013 Jan 11.

PMID:
23313257
9.

The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.

Messager M, Lefevre JH, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C; FREGAT working group - FRENCH.

Ann Surg. 2011 Nov;254(5):684-93; discussion 693. doi: 10.1097/SLA.0b013e3182352647.

PMID:
22005144
10.

Calcipotriol and PUVA as treatment for vitiligo.

Cherif F, Azaiz MI, Ben Hamida A, Ben O, Dhari A.

Dermatol Online J. 2003 Dec;9(5):4.

Supplemental Content

Loading ...
Support Center